CCL2 has also been shown to mediate its tumor-supportive ability by acting as a potent chemoattractant for MDSCs (Fujita et al., 2011) and unpolarized monocytes while contributing to polarization of monocytes to MDSCs by increasing their CD206 expression (Roca et al., 2009). Here, CCL2 is linked to neoplasm.